Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%
- Check20 days agoChange DetectedVersion metadata updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
- Check27 days agoChange Detected- Core content updated: results are now submitted/available. - Previously present note that no results were posted has been removed.SummaryDifference0.1%
- Check35 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element; overall content remains unchanged.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new topics related to colorectal cancer and specific medications like regorafenib and pembrolizumab. However, several previous location details and pharmacological terms have been removed.SummaryDifference2%
Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.